Surfactant Protein a (SP-A) Is a Prognostic Molecular Biomarker in Acute Respiratory Distress Syndrome

Obshchaya Reanimatologiya - Russian Federation
doi 10.15360/1813-9779-2013-3-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FSBI SRIGR RAMS

Related search

Cholestenoic Acid Is a Prognostic Biomarker in Acute Respiratory Distress Syndrome

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Surfactant Treatment for Acute Respiratory Distress Syndrome

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1999English

Surfactant Medication for Acute Respiratory Distress Syndrome

Thorax
PulmonaryRespiratory Medicine
1997English

Surfactant Protein-B Polymorphisms and Mortality in the Acute Respiratory Distress Syndrome*

Critical Care Medicine
Critical CareIntensive Care Medicine
2008English

Surfactant Protein (SP) B Associations and Interactions With SP-A in White and Black Subjects With Respiratory Distress Syndrome

Pediatrics International
Child HealthPediatricsPerinatology
2001English

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

New England Journal of Medicine
Medicine
2004English

A Rare Cause of Acute Respiratory Distress Syndrome

Journal of Anesthesia & Critical Care: Open Access
2016English

Treatment of Acute Respiratory Distress Syndrome in Secondary Surfactant Deficiency in Neonates

Paediatrica Indonesiana
2007English

Exogenous Surfactant Therapy for Pediatric Patients With Acute Respiratory Distress Syndrome

Canadian Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy